Market Pathways Top 5 February 2023
The top five Market Pathways articles posted in February to MyStrategist.com: Dirksen Lehman on Edwards Lifesciences’ pioneering strategy to obtain TAVR reimbursement, attorney Erik Vollebregt on big changes afoot for the EU MDR, CMS/MEDCAC ponders updates to CED and TCET; new cybersecurity guidance from Singapore, and in the debut of our Consultants Corner column, Adi Renbaum on the importance of reimbursement planning for building a company’s value proposition.